Cancer Stem Cells: A Comprehensive Review on Identification and Therapeutic Implications

Overview

Journal J Oral Maxillofac Pathol

Date 2020 Jun 9

PMID 32508482

Citations 11

Authors

B R Varun

P Jayanthi

Pratibha Ramani

Affiliations

Soon will be listed here.

Abstract

Cancer stem cells (CSCs) are distinct subpopulations of tumor cells that possess the ability for perpetual self-renewal and proliferation. They produce downstream progenitor cells and cancer cells that drive tumor growth. Studies of many cancer types including oral squamous cell carcinoma (OSCC) have identified CSCs using specific markers, but it is still unclear as to where in the stem cell hierarchy these markers fall. This is compounded further by the presence of multiple CSC subtypes within OSCC, making investigation reliant on the use of multiple markers. This review paper focuses on the current knowledge in CSC markers including OCT4, SOX2, NANOG, aldehyde dehydrogenase 1, CD44, CD24, CD133 and Musashi-1, highlighting their use and validity in OSCC CSC research.

Citing Articles

Medicinal plants as a potential resource for the discovery of novel structures towards cancer drug resistance treatment.

Nguyen M, Nguyen T, Le T, Le T, Chau N, Le T Heliyon. 2024; 10(20):e39229.

PMID: 39492898 PMC: 11530815. DOI: 10.1016/j.heliyon.2024.e39229.

CD44 in Bladder Cancer.

Duex J, Theodorescu D Cancers (Basel). 2024; 16(6).

PMID: 38539529 PMC: 10969618. DOI: 10.3390/cancers16061195.

Identification and Validation of a Prognostic Signature Derived from the Cancer Stem Cells for Oral Squamous Cell Carcinoma.

Shi M, Huang K, Wei J, Wang S, Yang W, Wang H Int J Mol Sci. 2024; 25(2).

PMID: 38256104 PMC: 10816075. DOI: 10.3390/ijms25021031.

Panoramic view of key cross-talks underpinning the oral squamous cell carcinoma stemness - unearthing the future opportunities.

Vastrad S, Ritesh G, S V S, Saraswathy G, Augustine D, Alzahrani K Front Oncol. 2024; 13:1247399.

PMID: 38170015 PMC: 10759990. DOI: 10.3389/fonc.2023.1247399.

Cancer stem cells: a target for overcoming therapeutic resistance and relapse.

Zhang S, Yang R, Ouyang Y, Shen Y, Hu L, Xu C Cancer Biol Med. 2024; .

PMID: 38164743 PMC: 10845928. DOI: 10.20892/j.issn.2095-3941.2023.0333.

References

Michifuri Y, Hirohashi Y, Torigoe T, Miyazaki A, Kobayashi J, Sasaki T . High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis. Pathol Int. 2012; 62(10):684-9. DOI: 10.1111/j.1440-1827.2012.02851.x. View

Warnakulasuriya S . Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2008; 45(4-5):309-16. DOI: 10.1016/j.oraloncology.2008.06.002. View

Baillie R, Tan S, Itinteang T . Cancer Stem Cells in Oral Cavity Squamous Cell Carcinoma: A Review. Front Oncol. 2017; 7:112. PMC: 5454033. DOI: 10.3389/fonc.2017.00112. View

Oliveira L, Castilho-Fernandes A, Oliveira-Costa J, Soares F, Zucoloto S, Ribeiro-Silva A . CD44+/CD133+ immunophenotype and matrix metalloproteinase-9: Influence on prognosis in early-stage oral squamous cell carcinoma. Head Neck. 2013; 36(12):1718-26. DOI: 10.1002/hed.23527. View

Yu H, Featherston T, Tan S, Chibnall A, Brasch H, Davis P . Characterization of Cancer Stem Cells in Moderately Differentiated Buccal Mucosal Squamous Cell Carcinoma. Front Surg. 2016; 3:46. PMC: 4970507. DOI: 10.3389/fsurg.2016.00046. View

Ravindran G, Devaraj H . Aberrant expression of CD133 and musashi-1 in preneoplastic and neoplastic human oral squamous epithelium and their correlation with clinicopathological factors. Head Neck. 2011; 34(8):1129-35. DOI: 10.1002/hed.21896. View

Ram R, Brasch H, Dunne J, Davis P, Tan S, Itinteang T . The Identification of Three Cancer Stem Cell Subpopulations within Moderately Differentiated Lip Squamous Cell Carcinoma. Front Surg. 2017; 4:12. PMC: 5337496. DOI: 10.3389/fsurg.2017.00012. View

Fu T, Hsieh I, Cheng J, Tsai M, Hou Y, Lee J . Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression. J Oral Pathol Med. 2015; 45(2):89-95. DOI: 10.1111/jop.12335. View

Tang C, Ang B, Pervaiz S . Cancer stem cell: target for anti-cancer therapy. FASEB J. 2007; 21(14):3777-85. DOI: 10.1096/fj.07-8560rev. View

10.

Tsai L, Hu F, Lee S, Yu C, Yu C, Chang Y . Oct4 mediates tumor initiating properties in oral squamous cell carcinomas through the regulation of epithelial-mesenchymal transition. PLoS One. 2014; 9(1):e87207. PMC: 3903644. DOI: 10.1371/journal.pone.0087207. View

11.

Zhang Q, Shi S, Yen Y, Brown J, Ta J, Le A . A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett. 2009; 289(2):151-60. DOI: 10.1016/j.canlet.2009.08.010. View

12.

Ghuwalewala S, Ghatak D, Das P, Dey S, Sarkar S, Alam N . CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma. Stem Cell Res. 2016; 16(2):405-17. DOI: 10.1016/j.scr.2016.02.028. View

13.

Chiou S, Yu C, Huang C, Lin S, Liu C, Tsai T . Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res. 2008; 14(13):4085-95. DOI: 10.1158/1078-0432.CCR-07-4404. View

14.

Liu W, Wu L, Shen X, Shi L, Zhang C, Xu L . Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia. Int J Cancer. 2012; 132(4):868-74. DOI: 10.1002/ijc.27720. View

15.

Pozzi V, Sartini D, Rocchetti R, Santarelli A, Rubini C, Morganti S . Identification and characterization of cancer stem cells from head and neck squamous cell carcinoma cell lines. Cell Physiol Biochem. 2015; 36(2):784-98. DOI: 10.1159/000430138. View

16.

Quintanilla Jr R, Asprer J, Vaz C, Tanavde V, Lakshmipathy U . CD44 is a negative cell surface marker for pluripotent stem cell identification during human fibroblast reprogramming. PLoS One. 2014; 9(1):e85419. PMC: 3887044. DOI: 10.1371/journal.pone.0085419. View

17.

Chou M, Hu F, Yu C, Yu C . Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells. Oral Oncol. 2014; 51(1):31-9. DOI: 10.1016/j.oraloncology.2014.10.002. View

18.

Todoroki K, Ogasawara S, Akiba J, Nakayama M, Naito Y, Seki N . CD44v3+/CD24- cells possess cancer stem cell-like properties in human oral squamous cell carcinoma. Int J Oncol. 2015; 48(1):99-109. PMC: 4734600. DOI: 10.3892/ijo.2015.3261. View

19.

Braumuller H, Gansauge S, Ramadani M, Gansauge F . CD44v6 cell surface expression is a common feature of macrophages and macrophage-like cells - implication for a natural macrophage extravasation mechanism mimicked by tumor cells. FEBS Lett. 2000; 476(3):240-7. DOI: 10.1016/s0014-5793(00)01737-3. View

20.

Zou B, Sun S, Qi X, Ji P . Aldehyde dehydrogenase activity is a cancer stem cell marker of tongue squamous cell carcinoma. Mol Med Rep. 2012; 5(4):1116-20. PMC: 3493091. DOI: 10.3892/mmr.2012.781. View